Ally Bridge Group (ABG)

	Start	2017-03-23 existent
	Industry	private equity
	Industry 2	healthcare

	Region	Hong Kong
	Country	China
	City	n. a.
		Address record changed: 2017-03-02

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	1,500,000,000 (assets, managed (2017) 2017-02-24)


		Record changed: 2023-10-26

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Ally Bridge Group (ABG)

[1] Shoreline Biosciences, Inc.. (11/2/21). "Press Release: Shoreline Biosciences Announces $140M Financing to Advance Pipeline of Next Generation Cell Immunotherapies". San Diego, CA....
[2] Sonoma Biotherapeutics Inc.. (8/4/21). "Press Release: Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases". So...
[3] Grail, Inc.. (5/21/18). "Press Release: Grail Announces $300 Million Raised in Oversubscribed Series C Financing". Menlo Park, CA & Hong Kong....
[4] Noda, Tomas S., III [DealStreatAsia.com]. (2/23/17). "News: HK’s Ally Bridge Group Backs Two European Life Science Firms"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]